Bio-Rad Laboratories
BIO
#1775
Rank
NZ$16.30 B
Marketcap
$582.03
Share price
-1.10%
Change (1 day)
18.02%
Change (1 year)
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.

Operating Margin for Bio-Rad Laboratories (BIO)

Operating Margin as of December 2024 (TTM): -38.95%

According to Bio-Rad Laboratories's latest financial reports and stock price the company's current Operating Margin is -38.95%. At the end of 2023 the company had an Operating Margin of -31.82%.

Operating Margin history for Bio-Rad Laboratories from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-31.82%-81.04%
2022-167.87%-190.04%
2021186.45%-3.49%
2020193.19%97.52%
201997.81%336.81%
201822.39%394.57%
20174.53%125.31%
20162.01%-72.18%
20157.22%19.4%
20146.05%14.78%
20135.27%-52.57%
201211.11%-6.29%
201111.86%3.72%
201011.43%9.75%
200910.42%28.65%
20088.10%-2.12%
20078.27%-25.81%
200611.15%41.01%
20057.91%-11.45%
20048.93%-24.17%
200311.78%-3.19%
200212.16%53.06%
20017.95%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.13%-136.28%๐Ÿ‡บ๐Ÿ‡ธ USA
16.13%-141.41%๐Ÿ‡บ๐Ÿ‡ธ USA
9.94%-125.52%๐Ÿ‡บ๐Ÿ‡ธ USA
23.70%-160.85%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-145.39%๐Ÿ‡บ๐Ÿ‡ธ USA
21.11%-154.20%๐Ÿ‡บ๐Ÿ‡ธ USA
14.99%-138.49%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.